November
First India-developed drug approved
India’s drug regulator gives conditional marketing approval to Ranbaxy’s anti-malaria drug – potentially the first non-generic drug developed by an Indian company
01 Nov 2011
New starters at iS Health Group
iS Health Group has recruited two new members to its project management team: Roda Muggeridge and Anthony Barron
01 Nov 2011
BMS' Anthony Hooper joins Amgen
Amgen has appointed Anthony (Tony) Hooper as executive vice president, global commercial operations
02 Nov 2011
Teva UK appoints Richard Daniell managing director
Teva UK promotes Richard Daniell to managing director. He succeeds Dipankar Bhattacharjee who has in turn been promoted to a wider European role
02 Nov 2011
Pfizer's Q3 lifted by Prevenar, Enbrel and Lyrica
Sales growth of 7 per cent helped US-based pharma company’s adjusted income increase 11 per cent to $4.82bn in the third quarter
02 Nov 2011
Taiwan launches government-sponsored biotech incubator
The Supra Incubator Center (SIC) will focus on promoting the country's biotechnology sector
02 Nov 2011
Prof Tevor Jones oversees Synexus scientific advisory board
Steps down as chairman at clinical trial research firm in favour of Alan Pilgrim
03 Nov 2011
Dr Angelika Bodenteich joins Marinomed Biotechnologie
Dr Angelika Bodenteich takes up a role as head of development at the Austrian biotech company
03 Nov 2011
Quintiles scoops three US awards
Quintiles has won two International Davey Awards and a Web Health Award in recognition of its digital efforts to bridge the gaps between clinical research, patients and clinical trial participants
07 Nov 2011
KP360 moves into new NJ headquarters
KnowledgePoint360 Group has relocated from Secaucus to new headquarters in neighbouring Lyndhurst, New Jersey, US
08 Nov 2011